Đang chuẩn bị liên kết để tải về tài liệu:
Adjuvant therapy in the treatment of gallbladder cancer: A meta-analysis

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The benefit of adjuvant therapy (AT) for gallbladder cancer (GBC) is unclear as evidenced by conflicting results from nonrandomized studies. Here we aimed to perform a meta-analysis to determine the impact of AT on overall survival (OS). |

TÀI LIỆU LIÊN QUAN

Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma

Adjuvant therapy in the treatment of gallbladder cancer: A meta-analysis

Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer: A NCDB analysis

Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review